HIV
From the Journals
TDF use in HBV-HIV coinfection linked with kidney, bone issues
From the Journals
OTC meds, supplements, and other drugs may interact with HIV antiretrovirals
“Potential drug-drug interactions were common among our study population.”
From the Journals
Decentralizing PrEP offers a road map for retention
From the Journals
New HIV care guidelines from the European AIDS Clinical Society
Latest News
Most at-home STI testing kits fail to meet young people’s needs
Many programs are limited to adults, leaving teens with few options, and tests can be costly.
From the Journals
Polypharmacy common among patients aged 65 or older with HIV
Latest News
Counterfeit HIV drugs: Justice Department opens investigation
Clinicians are encouraged to inform HIV patients about the risks associated with counterfeit medications, how to determine whether the drugs they’...
Latest News
Protease inhibitors increase small-for-gestational-age but not other pregnancy risks
Protease inhibitors remain an important option for pregnant women living with HIV if other treatments are unsuitable or unavailable.
News
FDA approves HIV injectable Cabenuva initiation without oral lead-in
Cabenuva injections may be given as few as six times a year to manage HIV.
Feature
More questions than answers when managing HIV and menopause
From the Journals
Antiretroviral therapy associated with less risk of preterm birth